Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Malignant Melanoma

  Free Subscription


01.12.2025

2 BMC Cancer
1 Br J Cancer
1 Br J Dermatol
1 Eur J Dermatol
3 J Am Acad Dermatol
1 J Invest Dermatol
1 J Surg Oncol
2 Oncogene
1 PLoS Biol
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Cancer

  1. BUJA A, Cassalia F, Rugge M, Trevisiol C, et al
    Impact of comorbidities on survival in melanoma patients.
    BMC Cancer. 2025 Nov 25. doi: 10.1186/s12885-025-15376.
    PubMed         Abstract available

  2. ZHAO M, Zhao L, Yang Y, Wang F, et al
    Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNA.
    BMC Cancer. 2025;25:1808.
    PubMed         Abstract available


    Br J Cancer

  3. GAETA A, Nuvoli L, Doccioli C, Caini S, et al
    Sex and gender influence on adverse events for melanoma patients: a comprehensive review and meta-analysis.
    Br J Cancer. 2025 Nov 22. doi: 10.1038/s41416-025-03266.
    PubMed         Abstract available


    Br J Dermatol

  4. MARJANOVIC M, Mikiver R, Nielsen K, Isaksson K, et al
    Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma: A Nationwide Population-Based Registry Study from Sweden.
    Br J Dermatol. 2025 Nov 26:ljaf478. doi: 10.1093.
    PubMed         Abstract available


    Eur J Dermatol

  5. GONZALEZ JM, Sanchez BR, Briones LJ, Goller S, et al
    Journal Club. Genetic pathways in melanoma: molecular foundations and clinical implications.
    Eur J Dermatol. 2025;35:442-444.
    PubMed        


    J Am Acad Dermatol

  6. NGUYEN TM, Tran TS, Tran HT, Markovic SN, et al
    Disparities in Survival Outcomes Between Hispanic and Non-Hispanic Patients With Metastatic Cutaneous Melanoma in the Immunotherapy Era: Insights from SEER Database Analysis.
    J Am Acad Dermatol. 2025 Nov 25:S0190-9622(25)03248.
    PubMed        

  7. GILL M, Yang S, Kim D, Babaei N, et al
    "Response to Factors associated with adherence to skin self-examination recommendations for melanoma patients: a prospective cohort study".
    J Am Acad Dermatol. 2025 Nov 22:S0190-9622(25)03276.
    PubMed        

  8. SCHNEIDER J, Hill J, Varra V, Posligua A, et al
    Chemoprophylactic Effect of PD-1/PD-L1 Inhibitor Treatment on Non-Melanoma Skin Cancer Development.
    J Am Acad Dermatol. 2025 Nov 21:S0190-9622(25)03268.
    PubMed        


    J Invest Dermatol

  9. RAJA DAVID ISAC EB, Sigurbjornsdottir S, Dilshat R, Cornell RA, et al
    Phenotype switching in melanoma cells: MITF regulates the expression of CDH1 through E-boxes in an intronic region.
    J Invest Dermatol. 2025 Nov 26:S0022-202X(25)03605.
    PubMed         Abstract available


    J Surg Oncol

  10. LI RA, Nguyen AT, Bajaj K, Coles BM, et al
    Disparities in Cutaneous Melanoma Diagnosis and Survival Among American Indian and Alaskan Native Patients: A Systematic Review and Meta-Analysis.
    J Surg Oncol. 2025 Nov 24. doi: 10.1002/jso.70136.
    PubMed         Abstract available


    Oncogene

  11. XU X, Jarajapu V, Chadourne M, Soto-Vargas Z, et al
    FRA1 drives melanoma metastasis through an actionable transcriptional network.
    Oncogene. 2025 Nov 24. doi: 10.1038/s41388-025-03632.
    PubMed         Abstract available

  12. TAKAHASHI R, Yamamoto K, Toya H, Shoji H, et al
    A selective RPL15 PROTAC degrader enhances anti-PD-1 immunotherapy in a murine melanoma tumor model.
    Oncogene. 2025 Nov 23. doi: 10.1038/s41388-025-03641.
    PubMed         Abstract available


    PLoS Biol

  13. MAO F, Wu S, Allison DB, He D, et al
    The cell cycle regulator PLK1 promotes murine melanoma progression by regulating the transcription factor BACH1.
    PLoS Biol. 2025;23:e3003490.
    PubMed         Abstract available


    PLoS One

  14. ZENG J, Lin L, Ma Y, Huang W, et al
    Single-cell transcriptomics profiling reveals cellular origins and molecular drivers underlying melanoma brain metastasis.
    PLoS One. 2025;20:e0336502.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.